Login / Signup
Daishi Shimada
ORCID
Publication Activity (10 Years)
Years Active: 2021-2024
Publications (10 Years): 7
Top Topics
Nucleic Acid
Peripheral Blood
Low Dose
Respiratory Syncytial Virus
Top Venues
Infection and drug resistance
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Daishi Shimada
,
Masafumi Seki
Effectiveness of Drip Infusion of Lascufloxacin, a Novel Fluoroquinolone Antibiotic, for Patients with Pneumonia Including Chronic Lung Disease Exacerbations and Lung Abscesses.
Infection and drug resistance
17 (2024)
Daishi Shimada
,
Masafumi Seki
Severe Respiratory Syncytial Virus Infections in Elderly Persons During the COVID-19 Pandemic.
Infection and drug resistance
17 (2024)
Daishi Shimada
,
Masafumi Seki
Effectiveness of Drip Infusion of Lascufloxacin, a Novel Fluoroquinolone Antibiotic, for Patients with Pneumonia Including Chronic Lung Disease Exacerbations and Lung Abscesses.
Infection and drug resistance
17 (2024)
Daishi Shimada
,
Masafumi Seki
Severe Respiratory Syncytial Virus Infections in Elderly Persons During the COVID-19 Pandemic.
Infection and drug resistance
17 (2024)
Daishi Shimada
,
Motoyasu Sagawa
,
Masafumi Seki
Detection of Mycobacterium avium-intracellulare Complex (MAC) by Bronchial Lavage and the Relationship with Titers of Anti-Glycopeptidolipid-Core IgA Antibodies to MAC in Patients with Pulmonary MAC Disease.
Infection and drug resistance
16 (2023)
Daishi Shimada
,
Motoyasu Sagawa
,
Masafumi Seki
Detection of Mycobacterium avium-intracellulare Complex (MAC) by Bronchial Lavage and the Relationship with Titers of Anti-Glycopeptidolipid-Core IgA Antibodies to MAC in Patients with Pulmonary MAC Disease.
Infection and drug resistance
16 (2023)
Haruka Imai
,
Yuji Watanabe
,
Daishi Shimada
,
Jun Suzuki
,
Shiro Endo
,
Mitsuo Kaku
,
Masafumi Seki
Utility of a Cell-Direct Polymerase Chain Reaction-Based Nucleic Acid Lateral Flow Immunoassay for Detection of Bacteria in Peripheral Blood Leukocytes of Suspected Sepsis Cases.
Infection and drug resistance
14 (2021)